Skip to content

The assessment of effect of commercial chlorhexidine and conventional tooth flosses on gingivitis reduction: Randomized clinical trial

The assessment of effect of commercial chlorhexidine and conventional tooth flosses on gingivitis reduction: Randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210305050584N1
Enrollment
51
Registered
2021-11-17
Start date
2021-10-21
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gingivitis. Gingivitis and periodontal diseases

Interventions

Intervention 1: Intervention group: Use chlorhexidine toothfloss once a day before sleeping for 2 months. Intervention 2: Control group: Use c conventional toothfloss once a day before bed for 2 month

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Lack of systemic disease Existence of bleeding on probing (BOP) in at least one dental space in each quadrant (one quarter of the jaw) Maximum pocket depth is 2 mm and no gingival recession Gingival index loe & sillness more than 1.5 At least 5 teeth per quadrant Maximum interdental space is 1 mm

Exclusion criteria

Exclusion criteria: smoking Use of any type of dental prosthesis appliance, orthodontics, cavities or any plaque blocking agent other than calculus Use of systemic antibiotics in the last 3 months before the start of the study Use of drugs that affect the condition of the gums. Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) Consumption of mouthwash in the last 6 months Systemic diseases that cause changes in periodontal health, such as diabetes, hormonal problems, patients at risk for endocarditis, pregnant women and nursing mothers. Existence of oral diseases other than gingivitis parafunctional habits malocclusion

Design outcomes

Primary

MeasureTime frame
Gingival index. Timepoint: Baseline and 2,4,8 weeks after intervention. Method of measurement: Löe&Sillness gingival index.;Bleeding on probing index. Timepoint: Baseline and 2,4,8 weeks after intervention. Method of measurement: Ainamo&Bay bleeding on probing index.;Plaque index. Timepoint: Baseline and 2,4,8 weeks after intervention. Method of measurement: Turesky modified Quigley-hein index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSheyda Fazlalizadeh

Ardabil University of Medical Sciences

sh.fazlalizade@gmail.com(045) 33534790-33534798

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026